Dr. James P. Smith, MD
Pulmonology (Pulmonary Disease Physician)
- Medicare participating
At a glance
- Medical school
- Louisiana State University School of Medicine in Shreveport (1996)
- Years since graduation
- 30
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 278
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1996Medical school: Louisiana State University School of Medicine in Shreveport
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
NC license 200500593 -
Critical Care Medicine (Internal Medicine) Physician
NC license 200500593 -
Internal Medicine Physician
NC license 200500593 -
Sleep Medicine (Internal Medicine) Physician
NC license 2005-00593
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Novant Health Presbyterian Medical Center Charlotte, NC
- Novant Health Matthews Medical Center Matthews, NC
- Novant Health Huntersville Medical Center Huntersville, NC
- Novant Health Mint Hill Medical Center Charlotte, NC
- Novant Health Ballantyne Medical Center Charlotte, NC
Medical groups
- Novant Health Medical Group, LLC (2,430 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 278
- Services billed
- 736
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 138 | 97 |
| Critical care, first 30-74 minutes | 111 | 42 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 66 | 34 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 62 | 37 |
| Established patient office or other outpatient visit, 40-54 minutes | 45 | 29 |
| X-ray of chest, 2 views | 26 | 22 |
| New patient office or other outpatient visit, 45-59 minutes | 25 | 25 |
| Test to measure expiratory airflow and volume | 18 | 18 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 15 | 14 |
| Test to measure rate of airflow | 13 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Charlotte, NC | 187 |
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Charlotte, NC | 140 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Charlotte, NC | 86 |
| Prednisone Other prescribers in Charlotte, NC | 68 |
| Anoro Ellipta (umeclidinium brm/vilanterol tr) Other prescribers in Charlotte, NC | 66 |
| Stiolto Respimat (tiotropium br/olodaterol hcl) Other prescribers in Charlotte, NC | 53 |
| Azithromycin Other prescribers in Charlotte, NC | 48 |
| Fluticasone Propionate Other prescribers in Charlotte, NC | 39 |
| Wixela Inhub (fluticasone propion/salmeterol) Other prescribers in Charlotte, NC | 39 |
| Montelukast Sodium Other prescribers in Charlotte, NC | 38 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 8 companies reported 16 payments worth $432 in total to this clinician.
| United Therapeutics Corporation | $97.05 |
|---|---|
| Insmed, Inc. | $79.34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $69.48 |
| AstraZeneca Pharmaceuticals LP | $45.82 |
| GlaxoSmithKline, LLC. | $42.09 |
| Merck Sharp & Dohme LLC | $39.92 |
| Regeneron Healthcare Solutions, Inc. | $31.59 |
| Verona Pharma, Inc. | $26.56 |
| Food and Beverage | $414 |
|---|---|
| Education | $17.38 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Insmed, Inc. Sep 11, 2025 | Education in-kind | $17.38 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.